Judge Approves $7.5 Million Class Settlement For Case Involving Premature Birth Drug
NEWARK, N.J. — A New Jersey federal judge granted final approval of a $7.5 million class action settlement to end claims that a drug manufacturer knew that its premature birth prevention...To view the full article, register now.
Already a subscriber? Click here to view full article